市場調査レポート

商品コード

1403481

陽子線治療システム市場の2030年までの予測：製品タイプ、タイプ、セットアップ、適応症、エンドユーザー、地域別の世界分析

Proton Therapy Systems Market Forecasts to 2030 - Global Analysis By Product Type, Type, Set-Up, Indication, End User and By Geography

出版日: 2024年01月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 595,815円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 753,742円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 911,669円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,076,775円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の陽子線治療システム市場は予測期間中15.6%のCAGRで成長しています。

陽子線治療システムは、精密ながん治療のために設計された先進医療技術であり、治療効果の向上とがん患者の生活の質の向上を提供します。陽子線治療は、腫瘍の形状に正確に線量を適合させることができるため、健康な組織を温存しながら、より高い線量をがん細胞に照射することができます。

WHO（世界保健機関）によると、がんは世界の主要な死因であり、2020年には約1,000万人が死亡するとされています。

増加するがん罹患率

陽子線治療は、放射線治療の高度な形態として、がん治療においていくつかの利点を提供します。陽子線を利用して腫瘍を正確に狙い撃ちし、周囲の健康な組織へのダメージを最小限に抑えながら、高い放射線量を照射します。この標的を絞ったアプローチは、従来の放射線療法に伴う副作用や長期合併症のリスクを軽減します。陽子線治療は、精密で正確な放射線照射が可能なことから、貴重な治療法として認知され、市場の需要を高めています。

限られたアクセシビリティ

陽子線治療は先進的で効果的な治療法であるが、従来の放射線治療施設と比較すると、陽子線治療センターの利用可能性やアクセス性は限られています。陽子線治療センターの地理的分布は、アクセスの制限に一役買っています。さらに、遠隔地や地方に居住する患者は、距離が遠く、近くに施設がないため、陽子線治療を受ける上で大きな課題に直面する可能性があります。そのため、アクセスのしにくさが市場拡大を妨げる大きな要因となっています。

技術の進歩

陽子線治療装置の設計と機能が改善され、洗練された治療計画システムと相まって、ヘルスケアプロバイダーは高度に的を絞った放射線量を照射できるようになった。高度な画像技術の統合は、腫瘍とその周囲の健康な組織をリアルタイムで可視化することにより、治療の精度を高める。さらに、治療計画におけるソフトウェアの技術革新は、個々の患者のニーズに合わせて陽子線治療を最適化し、個別化された適応的アプローチを促進します。したがって、こうした技術革新は市場の成長を加速させる。

代替技術の利用可能性

陽子線治療には独自の利点がある一方で、強度変調放射線治療（IMRT）や定位体放射線治療（SBRT）などの代替技術も著しく進歩しており、特定の症例では同等の治療成績が得られます。広く採用されている放射線治療法であるIMRTは、複数の放射線ビームを使用し、周囲の健康な組織への被曝を最小限に抑えながら、腫瘍に正確な線量を照射できるように調整できます。代替技術が利用可能であることが、市場拡大の課題となっています。

COVID-19の影響

陽子線治療システム市場は、COVID-19の大流行による大きな影響を経験しています。パンデミック時のヘルスケア予算に対する財政負担は投資決定に影響を及ぼし、陽子線治療システムの採用を減速させる可能性があります。しかし、パンデミックは技術革新と適応を促しました。遠隔医療ソリューションは、患者の診察やフォローアップにますます採用されるようになっています。治療に関連する副作用の軽減など陽子線治療の利点に対する認識が高まり、先進的ながん治療法の重要性が強調されています。

予測期間中、回転陽子線治療システム分野が最大となる見込み

回転陽子線治療システム分野が最大のシェアを占めると推定されます。回転陽子線治療システムは、患者の周囲を回転できるガントリーを利用し、さまざまな角度から腫瘍に放射線を照射する3次元的アプローチを提供します。このダイナミックな回転により、健康な組織への被ばくを最小限に抑えながら、がん細胞をより正確に狙い撃ちすることができます。さらに、複数の方向から陽子ビームを照射できるため、腫瘍の形状への適合性が向上し、複雑で不規則な形状の腫瘍に特に効果的です。

予測期間中にCAGRが最も高くなると予想されるのはビームデリバリーシステム分野です。

ビームデリバリーシステム分野は、予測期間中に有利な成長が見込まれます。このシステムは、陽子加速器から患者の体内の腫瘍部位への高エネルギー陽子ビームの照射を指示・制御する役割を担っています。陽子ビームの深さと強度は、エネルギー変調装置、磁石、コリメータなどのコンポーネントの組み合わせによって形成・変調されます。さらに、最新のビームデリバリーシステムはスキャニングまたはスポットスキャニング技術を組み込んでいることが多く、陽子ビームをスポットごとに照射することでさらに精度を高めることができます。

最大シェアの地域：

推定期間中、北米が最大の市場シェアを占めました。がんの罹患率の増加と陽子線治療の利点に対する意識の高まりが、こうした先進的なシステムの採用を後押ししています。米国では、有名ながん治療センターや研究機関が存在するため、技術革新と技術導入の環境が醸成され、陽子線治療ソリューションの開発と展開が推進されています。さらに、学術機関、ヘルスケア機関、業界関係者の連携が、陽子線治療の研究の進展とベストプラクティスの普及に貢献しています。

CAGRが最も高い地域：

欧州は予測期間中、収益性の高い成長が見込まれます。ドイツ、フランス、英国などの欧州諸国は、がん罹患率の上昇と革新的医療技術の重視の高まりにより、陽子線治療システムに対する強い需要を示しています。さらに、この地域は、先進的な陽子線治療ソリューションの開発と応用に積極的に取り組んでいる主要ながん治療センターや研究機関のネットワークを誇っています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

企業プロファイル
- 追加市場企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他の欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他のアジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他の南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他の中東・アフリカ

第11章主な発展

契約、パートナーシップ、コラボレーション、合弁事業
買収と合併
新製品の発売
事業拡大
その他の主要戦略

第12章企業プロファイル

Mitsubishi Electric Corporation
Mevion Medical Systems
Hitachi
Advanced Oncotherapy plc
Ion Beam Applications SA
IBA worldwide
Varian
Provision Healthcare
ProTom International

図表

List of Tables

Table 1 Global Proton Therapy Systems Market Outlook, By Region (2021-2030) ($MN)
Table 2 Global Proton Therapy Systems Market Outlook, By Product Type (2021-2030) ($MN)
Table 3 Global Proton Therapy Systems Market Outlook, By Nozzle and Image Viewers (2021-2030) ($MN)
Table 4 Global Proton Therapy Systems Market Outlook, By Accelerator (2021-2030) ($MN)
Table 5 Global Proton Therapy Systems Market Outlook, By Beam Transport System (2021-2030) ($MN)
Table 6 Global Proton Therapy Systems Market Outlook, By Patient Positioning System (2021-2030) ($MN)
Table 7 Global Proton Therapy Systems Market Outlook, By Beam Delivery System (2021-2030) ($MN)
Table 8 Global Proton Therapy Systems Market Outlook, By Type (2021-2030) ($MN)
Table 9 Global Proton Therapy Systems Market Outlook, By Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 10 Global Proton Therapy Systems Market Outlook, By Non-Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 11 Global Proton Therapy Systems Market Outlook, By Set-Up (2021-2030) ($MN)
Table 12 Global Proton Therapy Systems Market Outlook, By Single Room Systems (2021-2030) ($MN)
Table 13 Global Proton Therapy Systems Market Outlook, By Multiple Room Systems (2021-2030) ($MN)
Table 14 Global Proton Therapy Systems Market Outlook, By Indication (2021-2030) ($MN)
Table 15 Global Proton Therapy Systems Market Outlook, By Lung Cancer (2021-2030) ($MN)
Table 16 Global Proton Therapy Systems Market Outlook, By Gastro-Intestinal Cancer (2021-2030) ($MN)
Table 17 Global Proton Therapy Systems Market Outlook, By Breast Cancer (2021-2030) ($MN)
Table 18 Global Proton Therapy Systems Market Outlook, By Prostate Cancer (2021-2030) ($MN)
Table 19 Global Proton Therapy Systems Market Outlook, By Brain Cancer (2021-2030) ($MN)
Table 20 Global Proton Therapy Systems Market Outlook, By Head & Neck Cancer (2021-2030) ($MN)
Table 21 Global Proton Therapy Systems Market Outlook, By Pediatric Cancer (2021-2030) ($MN)
Table 22 Global Proton Therapy Systems Market Outlook, By Other Indications (2021-2030) ($MN)
Table 23 Global Proton Therapy Systems Market Outlook, By End User (2021-2030) ($MN)
Table 24 Global Proton Therapy Systems Market Outlook, By Hospitals (2021-2030) ($MN)
Table 25 Global Proton Therapy Systems Market Outlook, By Proton Therapy Centers (2021-2030) ($MN)
Table 26 Global Proton Therapy Systems Market Outlook, By Other End Users (2021-2030) ($MN)
Table 27 North America Proton Therapy Systems Market Outlook, By Country (2021-2030) ($MN)
Table 28 North America Proton Therapy Systems Market Outlook, By Product Type (2021-2030) ($MN)
Table 29 North America Proton Therapy Systems Market Outlook, By Nozzle and Image Viewers (2021-2030) ($MN)
Table 30 North America Proton Therapy Systems Market Outlook, By Accelerator (2021-2030) ($MN)
Table 31 North America Proton Therapy Systems Market Outlook, By Beam Transport System (2021-2030) ($MN)
Table 32 North America Proton Therapy Systems Market Outlook, By Patient Positioning System (2021-2030) ($MN)
Table 33 North America Proton Therapy Systems Market Outlook, By Beam Delivery System (2021-2030) ($MN)
Table 34 North America Proton Therapy Systems Market Outlook, By Type (2021-2030) ($MN)
Table 35 North America Proton Therapy Systems Market Outlook, By Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 36 North America Proton Therapy Systems Market Outlook, By Non-Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 37 North America Proton Therapy Systems Market Outlook, By Set-Up (2021-2030) ($MN)
Table 38 North America Proton Therapy Systems Market Outlook, By Single Room Systems (2021-2030) ($MN)
Table 39 North America Proton Therapy Systems Market Outlook, By Multiple Room Systems (2021-2030) ($MN)
Table 40 North America Proton Therapy Systems Market Outlook, By Indication (2021-2030) ($MN)
Table 41 North America Proton Therapy Systems Market Outlook, By Lung Cancer (2021-2030) ($MN)
Table 42 North America Proton Therapy Systems Market Outlook, By Gastro-Intestinal Cancer (2021-2030) ($MN)
Table 43 North America Proton Therapy Systems Market Outlook, By Breast Cancer (2021-2030) ($MN)
Table 44 North America Proton Therapy Systems Market Outlook, By Prostate Cancer (2021-2030) ($MN)
Table 45 North America Proton Therapy Systems Market Outlook, By Brain Cancer (2021-2030) ($MN)
Table 46 North America Proton Therapy Systems Market Outlook, By Head & Neck Cancer (2021-2030) ($MN)
Table 47 North America Proton Therapy Systems Market Outlook, By Pediatric Cancer (2021-2030) ($MN)
Table 48 North America Proton Therapy Systems Market Outlook, By Other Indications (2021-2030) ($MN)
Table 49 North America Proton Therapy Systems Market Outlook, By End User (2021-2030) ($MN)
Table 50 North America Proton Therapy Systems Market Outlook, By Hospitals (2021-2030) ($MN)
Table 51 North America Proton Therapy Systems Market Outlook, By Proton Therapy Centers (2021-2030) ($MN)
Table 52 North America Proton Therapy Systems Market Outlook, By Other End Users (2021-2030) ($MN)
Table 53 Europe Proton Therapy Systems Market Outlook, By Country (2021-2030) ($MN)
Table 54 Europe Proton Therapy Systems Market Outlook, By Product Type (2021-2030) ($MN)
Table 55 Europe Proton Therapy Systems Market Outlook, By Nozzle and Image Viewers (2021-2030) ($MN)
Table 56 Europe Proton Therapy Systems Market Outlook, By Accelerator (2021-2030) ($MN)
Table 57 Europe Proton Therapy Systems Market Outlook, By Beam Transport System (2021-2030) ($MN)
Table 58 Europe Proton Therapy Systems Market Outlook, By Patient Positioning System (2021-2030) ($MN)
Table 59 Europe Proton Therapy Systems Market Outlook, By Beam Delivery System (2021-2030) ($MN)
Table 60 Europe Proton Therapy Systems Market Outlook, By Type (2021-2030) ($MN)
Table 61 Europe Proton Therapy Systems Market Outlook, By Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 62 Europe Proton Therapy Systems Market Outlook, By Non-Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 63 Europe Proton Therapy Systems Market Outlook, By Set-Up (2021-2030) ($MN)
Table 64 Europe Proton Therapy Systems Market Outlook, By Single Room Systems (2021-2030) ($MN)
Table 65 Europe Proton Therapy Systems Market Outlook, By Multiple Room Systems (2021-2030) ($MN)
Table 66 Europe Proton Therapy Systems Market Outlook, By Indication (2021-2030) ($MN)
Table 67 Europe Proton Therapy Systems Market Outlook, By Lung Cancer (2021-2030) ($MN)
Table 68 Europe Proton Therapy Systems Market Outlook, By Gastro-Intestinal Cancer (2021-2030) ($MN)
Table 69 Europe Proton Therapy Systems Market Outlook, By Breast Cancer (2021-2030) ($MN)
Table 70 Europe Proton Therapy Systems Market Outlook, By Prostate Cancer (2021-2030) ($MN)
Table 71 Europe Proton Therapy Systems Market Outlook, By Brain Cancer (2021-2030) ($MN)
Table 72 Europe Proton Therapy Systems Market Outlook, By Head & Neck Cancer (2021-2030) ($MN)
Table 73 Europe Proton Therapy Systems Market Outlook, By Pediatric Cancer (2021-2030) ($MN)
Table 74 Europe Proton Therapy Systems Market Outlook, By Other Indications (2021-2030) ($MN)
Table 75 Europe Proton Therapy Systems Market Outlook, By End User (2021-2030) ($MN)
Table 76 Europe Proton Therapy Systems Market Outlook, By Hospitals (2021-2030) ($MN)
Table 77 Europe Proton Therapy Systems Market Outlook, By Proton Therapy Centers (2021-2030) ($MN)
Table 78 Europe Proton Therapy Systems Market Outlook, By Other End Users (2021-2030) ($MN)
Table 79 Asia Pacific Proton Therapy Systems Market Outlook, By Country (2021-2030) ($MN)
Table 80 Asia Pacific Proton Therapy Systems Market Outlook, By Product Type (2021-2030) ($MN)
Table 81 Asia Pacific Proton Therapy Systems Market Outlook, By Nozzle and Image Viewers (2021-2030) ($MN)
Table 82 Asia Pacific Proton Therapy Systems Market Outlook, By Accelerator (2021-2030) ($MN)
Table 83 Asia Pacific Proton Therapy Systems Market Outlook, By Beam Transport System (2021-2030) ($MN)
Table 84 Asia Pacific Proton Therapy Systems Market Outlook, By Patient Positioning System (2021-2030) ($MN)
Table 85 Asia Pacific Proton Therapy Systems Market Outlook, By Beam Delivery System (2021-2030) ($MN)
Table 86 Asia Pacific Proton Therapy Systems Market Outlook, By Type (2021-2030) ($MN)
Table 87 Asia Pacific Proton Therapy Systems Market Outlook, By Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 88 Asia Pacific Proton Therapy Systems Market Outlook, By Non-Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 89 Asia Pacific Proton Therapy Systems Market Outlook, By Set-Up (2021-2030) ($MN)
Table 90 Asia Pacific Proton Therapy Systems Market Outlook, By Single Room Systems (2021-2030) ($MN)
Table 91 Asia Pacific Proton Therapy Systems Market Outlook, By Multiple Room Systems (2021-2030) ($MN)
Table 92 Asia Pacific Proton Therapy Systems Market Outlook, By Indication (2021-2030) ($MN)
Table 93 Asia Pacific Proton Therapy Systems Market Outlook, By Lung Cancer (2021-2030) ($MN)
Table 94 Asia Pacific Proton Therapy Systems Market Outlook, By Gastro-Intestinal Cancer (2021-2030) ($MN)
Table 95 Asia Pacific Proton Therapy Systems Market Outlook, By Breast Cancer (2021-2030) ($MN)
Table 96 Asia Pacific Proton Therapy Systems Market Outlook, By Prostate Cancer (2021-2030) ($MN)
Table 97 Asia Pacific Proton Therapy Systems Market Outlook, By Brain Cancer (2021-2030) ($MN)
Table 98 Asia Pacific Proton Therapy Systems Market Outlook, By Head & Neck Cancer (2021-2030) ($MN)
Table 99 Asia Pacific Proton Therapy Systems Market Outlook, By Pediatric Cancer (2021-2030) ($MN)
Table 100 Asia Pacific Proton Therapy Systems Market Outlook, By Other Indications (2021-2030) ($MN)
Table 101 Asia Pacific Proton Therapy Systems Market Outlook, By End User (2021-2030) ($MN)
Table 102 Asia Pacific Proton Therapy Systems Market Outlook, By Hospitals (2021-2030) ($MN)
Table 103 Asia Pacific Proton Therapy Systems Market Outlook, By Proton Therapy Centers (2021-2030) ($MN)
Table 104 Asia Pacific Proton Therapy Systems Market Outlook, By Other End Users (2021-2030) ($MN)
Table 105 South America Proton Therapy Systems Market Outlook, By Country (2021-2030) ($MN)
Table 106 South America Proton Therapy Systems Market Outlook, By Product Type (2021-2030) ($MN)
Table 107 South America Proton Therapy Systems Market Outlook, By Nozzle and Image Viewers (2021-2030) ($MN)
Table 108 South America Proton Therapy Systems Market Outlook, By Accelerator (2021-2030) ($MN)
Table 109 South America Proton Therapy Systems Market Outlook, By Beam Transport System (2021-2030) ($MN)
Table 110 South America Proton Therapy Systems Market Outlook, By Patient Positioning System (2021-2030) ($MN)
Table 111 South America Proton Therapy Systems Market Outlook, By Beam Delivery System (2021-2030) ($MN)
Table 112 South America Proton Therapy Systems Market Outlook, By Type (2021-2030) ($MN)
Table 113 South America Proton Therapy Systems Market Outlook, By Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 114 South America Proton Therapy Systems Market Outlook, By Non-Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 115 South America Proton Therapy Systems Market Outlook, By Set-Up (2021-2030) ($MN)
Table 116 South America Proton Therapy Systems Market Outlook, By Single Room Systems (2021-2030) ($MN)
Table 117 South America Proton Therapy Systems Market Outlook, By Multiple Room Systems (2021-2030) ($MN)
Table 118 South America Proton Therapy Systems Market Outlook, By Indication (2021-2030) ($MN)
Table 119 South America Proton Therapy Systems Market Outlook, By Lung Cancer (2021-2030) ($MN)
Table 120 South America Proton Therapy Systems Market Outlook, By Gastro-Intestinal Cancer (2021-2030) ($MN)
Table 121 South America Proton Therapy Systems Market Outlook, By Breast Cancer (2021-2030) ($MN)
Table 122 South America Proton Therapy Systems Market Outlook, By Prostate Cancer (2021-2030) ($MN)
Table 123 South America Proton Therapy Systems Market Outlook, By Brain Cancer (2021-2030) ($MN)
Table 124 South America Proton Therapy Systems Market Outlook, By Head & Neck Cancer (2021-2030) ($MN)
Table 125 South America Proton Therapy Systems Market Outlook, By Pediatric Cancer (2021-2030) ($MN)
Table 126 South America Proton Therapy Systems Market Outlook, By Other Indications (2021-2030) ($MN)
Table 127 South America Proton Therapy Systems Market Outlook, By End User (2021-2030) ($MN)
Table 128 South America Proton Therapy Systems Market Outlook, By Hospitals (2021-2030) ($MN)
Table 129 South America Proton Therapy Systems Market Outlook, By Proton Therapy Centers (2021-2030) ($MN)
Table 130 South America Proton Therapy Systems Market Outlook, By Other End Users (2021-2030) ($MN)
Table 131 Middle East & Africa Proton Therapy Systems Market Outlook, By Country (2021-2030) ($MN)
Table 132 Middle East & Africa Proton Therapy Systems Market Outlook, By Product Type (2021-2030) ($MN)
Table 133 Middle East & Africa Proton Therapy Systems Market Outlook, By Nozzle and Image Viewers (2021-2030) ($MN)
Table 134 Middle East & Africa Proton Therapy Systems Market Outlook, By Accelerator (2021-2030) ($MN)
Table 135 Middle East & Africa Proton Therapy Systems Market Outlook, By Beam Transport System (2021-2030) ($MN)
Table 136 Middle East & Africa Proton Therapy Systems Market Outlook, By Patient Positioning System (2021-2030) ($MN)
Table 137 Middle East & Africa Proton Therapy Systems Market Outlook, By Beam Delivery System (2021-2030) ($MN)
Table 138 Middle East & Africa Proton Therapy Systems Market Outlook, By Type (2021-2030) ($MN)
Table 139 Middle East & Africa Proton Therapy Systems Market Outlook, By Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 140 Middle East & Africa Proton Therapy Systems Market Outlook, By Non-Rotating Proton Therapy Systems (2021-2030) ($MN)
Table 141 Middle East & Africa Proton Therapy Systems Market Outlook, By Set-Up (2021-2030) ($MN)
Table 142 Middle East & Africa Proton Therapy Systems Market Outlook, By Single Room Systems (2021-2030) ($MN)
Table 143 Middle East & Africa Proton Therapy Systems Market Outlook, By Multiple Room Systems (2021-2030) ($MN)
Table 144 Middle East & Africa Proton Therapy Systems Market Outlook, By Indication (2021-2030) ($MN)
Table 145 Middle East & Africa Proton Therapy Systems Market Outlook, By Lung Cancer (2021-2030) ($MN)
Table 146 Middle East & Africa Proton Therapy Systems Market Outlook, By Gastro-Intestinal Cancer (2021-2030) ($MN)
Table 147 Middle East & Africa Proton Therapy Systems Market Outlook, By Breast Cancer (2021-2030) ($MN)
Table 148 Middle East & Africa Proton Therapy Systems Market Outlook, By Prostate Cancer (2021-2030) ($MN)
Table 149 Middle East & Africa Proton Therapy Systems Market Outlook, By Brain Cancer (2021-2030) ($MN)
Table 150 Middle East & Africa Proton Therapy Systems Market Outlook, By Head & Neck Cancer (2021-2030) ($MN)
Table 151 Middle East & Africa Proton Therapy Systems Market Outlook, By Pediatric Cancer (2021-2030) ($MN)
Table 152 Middle East & Africa Proton Therapy Systems Market Outlook, By Other Indications (2021-2030) ($MN)
Table 153 Middle East & Africa Proton Therapy Systems Market Outlook, By End User (2021-2030) ($MN)
Table 154 Middle East & Africa Proton Therapy Systems Market Outlook, By Hospitals (2021-2030) ($MN)
Table 155 Middle East & Africa Proton Therapy Systems Market Outlook, By Proton Therapy Centers (2021-2030) ($MN)
Table 156 Middle East & Africa Proton Therapy Systems Market Outlook, By Other End Users (2021-2030) ($MN)

Product Code: SMRC24706

According to Stratistics MRC, the Global Proton Therapy Systems Market is growing at a CAGR of 15.6% during the forecast period. Proton therapy systems are advanced medical technologies designed for precise cancer treatment, offering enhanced therapeutic effectiveness and an improved quality of life for cancer patients. Proton therapy allows for precise dose conformity to the shape of the tumor, enabling higher radiation doses to be delivered to the cancer cells while sparing healthy tissues.

According to the WHO (World Health Organization), cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020.

Market Dynamics:

Driver:

Rising incidence of cancer

Proton therapy, as an advanced form of radiation therapy, offers several advantages in cancer treatment. It utilizes protons to precisely target tumours, delivering higher radiation doses while minimizing damage to surrounding healthy tissues. This targeted approach reduces the risk of side effects and long-term complications associated with conventional radiation therapy. Proton therapy, with its ability to provide precise and accurate radiation delivery, has gained recognition as a valuable treatment modality, which enhances market demand.

Restraint:

Limited accessibility

While proton therapy is an advanced and effective treatment modality, the availability and accessibility of proton therapy centers are limited compared to conventional radiation therapy facilities. The geographical distribution of proton therapy centers plays a role in limited accessibility. Moreover, patients residing in remote or rural areas may face significant challenges in accessing proton therapy due to the distance and lack of nearby facilities. Therefore, limited accessibility is a significant factor hampering market expansion.

Opportunity:

Technological advancements

Improved design and functionality of proton therapy machines, coupled with sophisticated treatment planning systems, enable healthcare providers to deliver highly targeted radiation doses. The integration of advanced imaging technologies enhances the accuracy of treatment delivery by providing real-time visualization of the tumor and surrounding healthy tissues. Furthermore, software innovations in treatment planning facilitate personalized and adaptive approaches, optimizing proton therapy for individual patient needs. Hence, these technological innovations accelerate market growth.

Threat:

Availability of alternative technologies

While proton therapy offers unique advantages, alternative technologies such as intensity-modulated radiation therapy (IMRT) and stereotactic body radiation therapy (SBRT) have also advanced significantly, providing comparable treatment outcomes in certain cases. IMRT, a widely adopted radiation therapy technique, uses multiple beams of radiation that can be adjusted to deliver precise doses to the tumor while minimizing exposure to surrounding healthy tissues. The availability of alternative technologies poses a challenge to market expansion.

COVID-19 Impact

The proton therapy systems market has experienced significant impacts from the COVID-19 pandemic. The financial strain on healthcare budgets during the pandemic has influenced investment decisions, potentially slowing down the adoption of proton therapy systems. However, the pandemic has also prompted innovation and adaptation. Telehealth solutions have been increasingly employed for patient consultations and follow-ups. Awareness of the benefits of proton therapy, such as reduced treatment-related side effects, has grown, emphasizing the importance of advanced cancer treatment modalities.

The rotating proton therapy systems segment is expected to be the largest during the forecast period

The rotating proton therapy systems segment is estimated to hold the largest share. Rotating proton therapy systems utilize a gantry that can rotate around the patient, providing a three-dimensional approach to irradiating tumours from various angles. This dynamic rotation allows for more precise targeting of cancerous cells while minimizing exposure to healthy tissues. Moreover, the ability to deliver proton beams from multiple directions enables improved conformity to the shape of the tumor, making it particularly effective for complex and irregularly shaped tumours.

The beam delivery system segment is expected to have the highest CAGR during the forecast period

The beam delivery system segment is anticipated to have lucrative growth during the forecast period. This system is responsible for directing and controlling the delivery of high-energy proton beams from the proton accelerator to the tumor site within the patient's body. The proton beam's depth and intensity are shaped and modulated by a combination of components, such as energy modulation devices, magnets, and collimators. Furthermore, modern beam delivery systems often incorporate scanning or spot-scanning techniques, allowing for even greater precision by delivering proton beams spot by spot.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The increasing incidence of cancer, coupled with a growing awareness of the benefits of proton therapy, drives the adoption of these advanced systems. In the United States, the presence of renowned cancer treatment centers and research institutions fosters a climate of innovation and technology adoption, propelling the development and deployment of proton therapy solutions. Additionally, collaborations between academic institutions, healthcare organizations, and industry players contribute to research advancements and the dissemination of best practices in proton therapy.

Region with highest CAGR:

Europe is expected to witness profitable growth over the projection period. European countries, including Germany, France, the United Kingdom, and others, exhibit a strong demand for proton therapy systems, driven by a rising incidence of cancer and an increasing emphasis on innovative medical technologies. Moreover, the region boasts a network of leading cancer treatment centers and research institutions actively engaged in the development and application of advanced proton therapy solutions.

Key players in the market:

Some of the key players in the Proton Therapy Systems Market include Mitsubishi Electric Corporation, Mevion Medical Systems, Hitachi, Advanced Oncotherapy plc, Ion Beam Applications SA, IBA worldwide, Varian, Provision Healthcare and ProTom International.

Key Developments:

In April 2023, Mitsubishi Electric India CNC has announced partnership with SolidCAM, a global leader in innovative CAM software for CNC machines and distribution of related digital manufacturing solutions.

In August 2022, IBA, the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer, announces it has signed a collaboration agreement with Apollo Hospitals Enterprise Ltd, to provide proton therapy training and education programs for IBA customers in Asia.

Product Types Covered:

Nozzle and Image Viewers
Accelerator
Beam Transport System
Patient Positioning System
Beam Delivery System

Types Covered:

Rotating Proton Therapy Systems
Non-Rotating Proton Therapy Systems

Set-Ups Covered:

Single Room Systems
Multiple Room Systems

Indications Covered:

Lung Cancer
Gastro-Intestinal Cancer
Breast Cancer
Prostate Cancer
Brain Cancer
Head & Neck Cancer
Paediatric Cancer
Other Indications

End Users Covered:

Hospitals
Proton Therapy Centers
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Proton Therapy Systems Market, By Product Type

5.1 Introduction
5.2 Nozzle and Image Viewers
5.3 Accelerator
5.4 Beam Transport System
5.5 Patient Positioning System
5.6 Beam Delivery System

6 Global Proton Therapy Systems Market, By Type

6.1 Introduction
6.2 Rotating Proton Therapy Systems
6.3 Non-Rotating Proton Therapy Systems

7 Global Proton Therapy Systems Market, By Set-Up

7.1 Introduction
7.2 Single Room Systems
7.3 Multiple Room Systems

8 Global Proton Therapy Systems Market, By Indication

8.1 Introduction
8.2 Lung Cancer
8.3 Gastro-Intestinal Cancer
8.4 Breast Cancer
8.5 Prostate Cancer
8.6 Brain Cancer
8.7 Head & Neck Cancer
8.8 Pediatric Cancer
8.9 Other Indications

9 Global Proton Therapy Systems Market, By End User

9.1 Introduction
9.2 Hospitals
9.3 Proton Therapy Centers
9.4 Other End Users

10 Global Proton Therapy Systems Market, By Geography

10.1 Introduction
10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa

11 Key Developments

11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies

12 Company Profiling

12.1 Mitsubishi Electric Corporation
12.2 Mevion Medical Systems
12.3 Hitachi
12.4 Advanced Oncotherapy plc
12.5 Ion Beam Applications SA
12.6 IBA worldwide
12.7 Varian
12.8 Provision Healthcare
12.9 ProTom International

陽子線治療システム市場の2030年までの予測：製品タイプ、タイプ、セットアップ、適応症、エンドユーザー、地域別の世界分析

Proton Therapy Systems Market Forecasts to 2030 - Global Analysis By Product Type, Type, Set-Up, Indication, End User and By Geography

増加するがん罹患率

限られたアクセシビリティ

技術の進歩

代替技術の利用可能性

COVID-19の影響

予測期間中、回転陽子線治療システム分野が最大となる見込み

予測期間中にCAGRが最も高くなると予想されるのはビームデリバリーシステム分野です。

最大シェアの地域：

CAGRが最も高い地域：

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の陽子線治療システム市場：製品タイプ別

第6章 世界の陽子線治療システム市場：タイプ別

第7章 世界の陽子線治療システム市場：セットアップ別

第8章 世界の陽子線治療システムの市場：適応症別

第9章 世界の陽子線治療システム市場：エンドユーザー別

第10章 世界の陽子線治療システム市場：地域別

第11章 主な発展

第12章 企業プロファイル